Medical devices, healthcare technology and the business of care
510(k) clearance · K261009

MobileLink Acetabular Cup System 40mm ID Inserts (various)

WALDEMAR LINK GmbH & Co. KG · Decision date Jul 6, 2026

FDA DECISIONK261009

What did the FDA decide?

FDA records K261009 as a 510(k) premarket notification, with a decision dated Jul 6, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Jul 6, 2026

FDA source record

Regulatory record facts

Identifier
K261009
Regulatory pathway
510(k) premarket notification
Product code
LZO
Decision code
SESE
Decision date
Jul 6, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented.

Product code
LZO
FDA device class
2

FDA decision timeline

  1. K261009 received

    Application receipt date recorded by FDA.

  2. K261009 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code LZO

Product / regulatory recordCompanyPathwayDecision dateSource
Microport Orthopedics, Inc.510(k) clearanceOct 1, 2026FDA
Medacta International S.A.510(k) clearanceSep 17, 2026FDA
United Orthopedic Corporation510(k) clearanceSep 2, 2026FDA
Zimmer, Inc.510(k) clearanceJun 16, 2026FDA
Zimmer, Inc.510(k) clearanceApr 27, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

WALDEMAR LINK GmbH & Co. KG

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Hamburg

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records